Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE.
By N. Segnan, P. Armaroli, L. Bonelli, M. Risio, S. Sciallero, M. Zappa, B. Andreoni, A. Arrigoni, L. Bisanti, C. Casella and 10 more. Journal of the National Cancer Institute, 2011
639 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/420bf2b6fc443f8090ec398090a42379ed527b46
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
Citations in the corpus
- ACG Clinical Guidelines: Colorectal Cancer Screening 2021. (2021, background): “Two trials, fromtheUnitedKingdom(Flexi Scope trial) and Italy (SCORE), offered once-only flexible sigmoidoscopy examination toparticipants age55–64years and reporteda reduction in CRC incidence by 23% and 18% and CRC mortality by 31% and 22%, respectively (56,57).”